
What’s Hot: NYR, CYC, EXP, KCN & AVE
What’s Not: EXR & TRE
What’s Hot
NYR – Nyrada Limited today closed up 39% to finish at 57.5c on $1m stock traded. There was no news out today but last week they announced the first patient was dosed in its PROTECT-MI Phase IIa Clinical Trial.
CYC – Cyclopharm Limited today closed up 26% to finish at 61c on $190k stock traded. The reason they were up today was because they announced a landmark agreement was signed with University Hospitals (UH) Cleveland, Ohio, US.
EXP – Experience Co Limited today closed up 25% to finish at 10c on $350k stock traded. The reason they were up today was because yesterday after market they announced a non-binding term sheet was signed with Inflite Group.
KCN – Kingsgate Consolidated Limited today closed up 16% to finish at $4.23 on $16.6m stock traded. The reason they were up today was because they announced an update on the remediation works underway at Plant 1 at the Chatree Gold Mine located in Thailand.
AVE – Avecho Biotechnology Limited today closed up 10% to finish at 2.2c on $300k stock traded. There was no news out today but last month they announced positive interim analysis for its Phase III insomnia program.
What’s Not
EXR – Elixir Energy Limited today closed down 17%% to finish at 10c on $3m stock traded. The reason they were down today was because they announced an operational update on the high impact Lorelle-3H appraisal well in ATP2056 within QLD’s Taroom Trough.
TRE – Toubani Resources Limited today closed down 13% to finish at 29.5c on $340k stock traded. The reason they were down today was because they announced a fully underwritten institutional entitlement offer to raise $52m @ 30c through Canaccord Genuity.
Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.
Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).